Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...
A drug already used to treat people who have diabetes and/or chronic kidney disease could have added heart disease benefits, ...
Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...
In recognition of World Kidney Day, the National Kidney Foundation (NKF) and Healthy.io are proud to partner in offering free ...
Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...
The FDA has granted a speedy review of Eli Lilly ... to reduce the risk of renal failure and cardiovascular death in people with chronic kidney disease (CKD). The new indication could unlock ...
Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...
Detailed price information for Xortx Therapeutics Inc (XRTX-X) from The Globe and Mail including charting and trades.
Stockhead on MSN9d
Health Check: All hail the hard-working bodily ‘spuds’ – it’s World Kidney DayMultiple peer-reviewed studies have shown that Promarker D can predict the onset of chronic kidney disease up to four years ...
GlobalData on MSN15d
FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKDThe US Food and Drug Administration (FDA) has approved scPharmaceuticals’ supplemental new drug application (sNDA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback